Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-071971
Filing Date
2025-05-15
Accepted
2025-05-15 07:10:42
Documents
59
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q caba-20250331.htm   iXBRL 10-Q 2194007
2 EX-31.1 caba-ex31_1.htm EX-31.1 18515
3 EX-31.2 caba-ex31_2.htm EX-31.2 18492
4 EX-32.1 caba-ex32_1.htm EX-32.1 10746
5 EX-32.2 caba-ex32_2.htm EX-32.2 11292
  Complete submission text file 0000950170-25-071971.txt   7376449

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20250331.xsd EX-101.SCH 977795
62 EXTRACTED XBRL INSTANCE DOCUMENT caba-20250331_htm.xml XML 1043788
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39103 | Film No.: 25948662
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)